Bringing Open Source To Biomedicine
waderoush writes "'Facebook and Twitter may have proven that humans have a deep-seated desire for sharing, [but] this impulse is still widely suppressed in biomedicine,' biotech reporter Luke Timmerman observes in this column on Sage Bionetworks founder Stephen Friend. Friend is working to convince drugmakers and academic researchers to pool their experimental genomic data in a shared database called the Sage Commons. The database could be used to track adverse drug events, or to 'visually display network models of disease that connect the dots between genes, proteins, and clinical manifestations of disease in ways that [scientific] journals are not equipped to handle,' Timmerman says. Researchers from Stanford, Columbia, UCSF, and UCSD are already contributing to the Sage Commons, and Friend is now calling for a community effort by drugmakers, academic scientists, doctors, regulators, insurers, and patients to 'grab this platform and run with it on their own."
there will no be any "openness" of any kind. There is just too much financial gain at stake (not that it is a good thing).
There are so many "standards" in place that it's impossible to implement systems to handle them all. What benefit do I get as a software creator if I implement this system which is still pretty much unestablished? Who is going to pay for the development to implement this? Contrary to popular belief scientists don't just sit down and code programs on their off time for fun, there are teams of people working on these projects as full time jobs.
Thing is, there is a lot of money involved Biomedicine. Research Institutes can hope to gain a lot of funding by selling their results to pharmaceutical companies. It would be the equivalent of Microsoft open sourcing the datasets used for their multibillion dollar speech and language technologies.
I can see this happening at universities though with a "GPLv2 equivalent" license on the database.
Anyone else read that as "Sega Bionetworks"?
I'd say it's more than sharing - it's about exposing ones thoughts in the desire for acknowledgement or acceptance .. I am not alone.
Also, useful for slagging others to prop up own self esteem and plugging ones own site/service/content or film one has participated in.
As for medicine .. I think it would be great to get more people on-line with folk remedies, to see if any actually have merit, i.e. chewing willow bark helped relieve my headache (this is the origin of Aspirin as salicylic acid.) The only worries I have, aside from a flood of quackery would be some billion dollar pharma concern buying up the track of land where the useful plant or bug lives and tries to patent the heck out of DNA or synthntesis to corner the market.
A feeling of having made the same mistake before: Deja Foobar
I am a little confused as to how and whether you cynics think open source works at all. Does it? It does for me in my selfish little world.
If the model works for some copywritable/patentable system then it is likely that it can be made to work for another. What's the problem?
Nolan
Drugmakers are already required to keep track of adverse drug events that arise during clinical testing. Much of this information is reported to regulatory agencies on almost a daily basis and there's a lot of work going behind the scenes to make sure the information is reliable, consistent and keeps patient privacy.
I can understand to some extent why drugmakers aren't too keen to jump into this. There is little use in adding yet another database into an already busy workflow. This new database is guaranteed to be different from many in-house solutions currently in use, so you will need to train people, get them used to the new process, etc. just to input the same data the regulator already receives. IMO this won't be worth the effort in the eyes of many drugmakers unless you get regulatory agencies involved.
I am not saying in general this is not a worthy cause. We currently have more data derived from genomics (and all the other -omics) than we can analyze. However to be successful this guys need to make sure they aren't duplicating the functionality of the myriad of public databases already out there.
TFT&TFS are as misleading as others have noted; this is about "open-data", not really "open-source".
I am skeptical and have two questions:
(1) In terms of research, isn't this what peer review and publication are supposed to accomplish?
(2) How is "biomedicine" different from "medicine"?
I was having a conversation with a friend big in biomedical research.
They are essentially trying to create a classifier for protein/drugs docking properties (I won't even pretend I get the geometry of these data, I just know the data is in a format usable for the non-continuous-input AI algo's, the most common ones). Apparently the possible positive gains from such a classifier are pretty intense (hell, a lab of people were doing this for free), yet the training data for their classifier is 4 sets. Yes, that is 4, as in "I'll use 3 sets for training and 1 for validation". Apparently, that's the entire set of data available in the public domain. To his knowledge, there are more datasets, yet the rest are available behind prohibitively expensive paywalls (prohibitive for a biomedical research lab for one of the wealthiest EU nations that is, not for me and you).
The amount of AI knowledge to pull off the research is easily within the grasp of a 3rd year CS student, yet the permanent research staff cannot make a breakthrough because they don't have access to the data.
As a little background I'm an unpaid intern at a university in a lab where we are currently working on a cure for Parkinson's Disease. I find this rather home hitting as we sort of hide our secrets horribly so (and in some ways, absolutely not) from outside sources. I also find it kind of interesting, as to the question of - what if we're all sharing information? How will competition play into the development of research, then?
Although truth be told, we know we're slightly behind in some areas compared to a few other research groups working on this - but we're getting really close. So far we've yielded near perfect "cure" results with DBS treatments.
Anywho, I babble on, but yeah. Open-data could really help the medical community and makes prices go down. But human greed always seems to get in the way.
discover the mysterious roots of the hymen, & associated value systems, real sex religious trainings? why a lost/missing hymen = further surgery, or even death by shame in some colonies? estimate the projectdead end (this week) of the never ending chosen ones' holycost life0cidal exterminations/business outings, & the costs to us, & profits to the royals etc...? with woz, stallman, torvalds, jobs & ventura looking on in a citizenly way, there'll be precious little eugenatic fudgepacking snaked by us god fearing/loving unchosens, again & again.
anything else that has it's base kode in the truth would also help.
Sage is a spinoff of Merck as Rosetta Inpharmatics. Rosetta died and Sage emerged from it. The spin was that Merck has deposited thousands of clinical mouse strains that supposedly worth tens of millions USD. I don't buy it.
I know Stephen Friend has been "promoting" his idea of pooling genetic data. The pitch is that by pooling, his company can offer "better" analysis. However, by "pooling" means for his company's (Sage) use and NOT for public good. This article is absolutely misleading! I'm speaking as someone who has dealt with Sage. So, Sage has been acting like a piggy bank. It's easy to deposit data, but it's really hard to get ANYTHING out. The reason is simple: they're ALWAYS citing NDA and privacy concerns (HIPAA among others).
Their supposed algorithms are lousy and shrouded with mysticism. They ALWAYS cite patents and/or proprietary rights. No source codes have been released so far. Read their papers / publications. They are FILLED with too many buzzwords and little detail. The important part are handwaved really vigorously into the paper. It bothers me why people trust them so much. Yes, they can produce good results, no doubt. But are they for open science? Definitely NOT!
Facebook and Twitter may have proven that humans have a deep-seated desire for sharing
If anything, sharing is merely a byproduct of the actual desires that drive those sites. Desires and tendencies such as showing off, egoism, seeking acceptance, seeking affirmation, or gathering information. And more so in the case of Facebook than Twitter, given the studies that repeatedly indicate that Twitter's graph is structured as a news graph rather than as a social graph (what was the last statistic? That the top 1% of Twitter users produce 98% of the tweets that get retweeted?).
To suggest that sharing is the driving desire behind those sites is to give humanity far more credit than it is due.
mbt shoes
mbt on sale
They tried this anonymous model when setting up the genetic database on Iceland. They failed. Commercial interests used lawyers to bypass all expectations of privacy and ended up being really dangerous to the public. Basically the people who donated caught DeCode in the act while doing sinister things, and used the legal system to opt out of the program. After that the legal advice anybody will get about taking a DNA-test is to not take the test. Anything you discover can and will be used against you to discriminate you. And it's especially the insurance-industry that will discriminate people because private companies are that way.
If the insurance-industry did not exist and all health-care was public, then sharing medical data would probably be okay. But, we are simply not there yet. Also the police sample all the databases they can get a hand on. Like in Norway, if you took at paternity-test, you would end up in the archive the people who investigate crimes uses. Knowing that some evidence get planted, this makes travesties of justice too easy to commit. No, keep your medical data confidential for now. The world is a place where the corporations and the governments will go to any means necessary to steal private data.
Easy, this is why: $
Except for the companies providing the publishing service, nobody makes money with your tweets. On the other hand, complex drug interaction and related biomedical info is a potential source of great return which is gathered at great risk for the company (they can spend millions on R&D and get nothing currently usable out of it). Biomed companies will not share info that a competitor could use.
~Syberz
have resources for this?
...soon to usher in the "lawsuit era for the bio-med hack" I can see it now...somewhere some how some yo-yo is going to state open source lead to a hack into some company's personal bottom line. (i.e. personel info, pay scale, profits info, secret formula for some new ED med...etc)
Joe Investor